Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single and Repeat Dosing Study of the Safety, Drug Exposure, and Clinical Activity of R-3750 in Patients With Mild to Moderate Ulcerative Colitis

NCT05666960 is registered in ClinicalTrials.gov with Rise Therapeutics LLC as lead sponsor.

NCT NCT05666960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05666960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single and Repeat Dosing Study of the Safety, Drug Exposure, and Clinical Activity of R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Lead sponsor
Rise Therapeutics LLC
Phase
Phase 1
Overall status
Recruiting
Start date
February 27, 2023
Completion date
October 31, 2026
Enrollment
36 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis, ulcerative colitis chronic, ulcerative colitis chronic mild, ulcerative colitis chronic moderate